Related Experiment Videos

Plasmid-mediated fosfomycin resistance is due to enzymatic modification of the antibiotic

Insights

Plasmid-mediated fosfomycin resistance involves intracellular inactivation of the antibiotic by a modifying enzyme. This enzyme, likely containing sulfhydryl groups, does not require cellular energy for its activity.

Area of Science:

  • Microbiology
  • Molecular Biology
  • Drug Resistance

Background:

  • Fosfomycin is a broad-spectrum antibiotic.
  • Plasmid-mediated resistance is a growing concern in infectious diseases.
  • The specific mechanisms of fosfomycin resistance require further elucidation.

Purpose of the Study:

  • To investigate the molecular mechanism of plasmid-mediated fosfomycin resistance.
  • To characterize the enzyme responsible for fosfomycin inactivation.

Main Methods:

  • Analysis of fosfomycin inactivation within bacterial cells.
  • Enzymatic modification assays using cell extracts.
  • Determination of energy dependence of the modification reaction.
  • Identification of key functional groups in the enzyme's active site.

Main Results:

  • Fosfomycin was inactivated intracellularly, with the modified antibiotic remaining within the cells.
  • A fosfomycin-modifying enzyme was identified in cell extracts.
  • The modification process was independent of cellular energy.
  • Evidence suggests the enzyme's active center contains sulfhydryl groups.

Conclusions:

  • Plasmid-mediated fosfomycin resistance is achieved through intracellular enzymatic inactivation.
  • The identified enzyme likely utilizes sulfhydryl groups for its catalytic activity.
  • Understanding this mechanism is crucial for combating fosfomycin resistance.

Related Concept Videos